Clinical Trial Details
Braintumor Website

[Information provided by: ClinicalTrials.gov, which provides patients, family members, and members of the public easy and free access to information on clinical studies for a wide range of diseases and conditions.]

NCT02844868 : Evaluation of the Observance and the Tolerance of a Motor Training Program
PhaseN/A
AgesMin: 18 Years Max: 75 Years
Eligibility
Inclusion Criteria:

- Having had a first ischemic stroke within 6 months.

- No recurrence.

- Responsible of a right or left hemiplegia.

- Able to walk alone with or without technical assistance.

- Over a distance of at least 10 meters.

- Performance on the six-minute walk test less than 400 meters.

- Without neurological history other than stroke.

Exclusion Criteria:

- Patients who did not have brain MRI after their stroke

- Patients with complete lesion of the primary motor cortex (as identified on MRI).

- Patients with an addiction to alcohol or drugs.

- Patients with psychiatric disease, cognitive impairment disease, uncontrolled
epilepsy, neoplastic disease, severe renal or pulmonary failure.

- Patients with cerebellar syndrome associated.

- Patients with clinical involvement of the brainstem (cranial nerve deficit).

- Patients who refused to sign the written consent.

- Patients who have an ongoing pregnancy.

- Patients under justice protection.

- Patients with contraindication to practice aerobic training after stress test.
LinksPermanent Link to THIS page: https://virtualtrials.com/nct/display1trial.cfm?nct=NCT02844868      |      Link to official Clinicaltrials.gov listing
Locations



Home | Brain Tumor Guide | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure Optune® | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us

Copyright (c) 1993 - 2019 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557
888-295-4740